Meta-analysis of effects of mobile phone application support on medication compliance of stroke patients
10.3760/cma.j.cn115682-20200613-03879
- VernacularTitle:手机应用支持对脑卒中患者服药依从性影响的Meta分析
- Author:
Xiaoying SUN
1
;
Ran AN
;
Yuying FAN
;
Guangming CHANG
;
Lili YU
Author Information
1. 哈尔滨医科大学护理学院 150086
- Keywords:
Stroke;
Meta-analysis;
Blood pressure;
Medication compliance;
Mobile phone
- From:
Chinese Journal of Modern Nursing
2021;27(5):604-609
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the effect of mobile phone application support on medication compliance of stroke patients.Methods:China National Knowledge Infrastructure (CNKI) , Wanfang, VIP Database, PubMed, Cochrane Library, Embase were searched by computer to select randomized controlled trial studies on the effect of mobile application support on medication compliance of stroke patients. According to the inclusion and exclusion criteria, researchers selected the literature, extracted data and evaluated the quality. RevMan 5.3 software was used for Meta-analysis and the retrieval time was from the establishment of databases until August 31, 2019.Results:A total of 10 randomized controlled trials (RCTs) were included. In terms of improving medication compliance, the results of subgroup analysis showed that mobile phone application support could improve medication compliance of stroke patients [ SMD=0.70, 95% CI (0.34-1.06) , P<0.000 01]. In terms of blood pressure control, mobile phone application support was effective in controlling systolic blood pressure [ MD=-8.11, 95% CI (-15.82--0.40) , P=0.04], but there was no statistically significant difference in its effect on diastolic blood pressure control ( P=0.34) . Conclusions:Mobile phone application support is effective in improving medication compliance and controlling systolic blood pressure in stroke patients. It can effectively control blood pressure fluctuations and improve prognosis of the disease. However, it is still uncertain whether diastolic blood pressure can be effectively controlled and a large number of multi-center, large-sample clinical randomized controlled trials are still needed to confirm its effects.
